Cargando…
Dihydroisotanshinone I as a Treatment Option for Head and Neck Squamous Cell Carcinomas
Head and neck squamous cell carcinomas (HNSCCs) are the most common cancers of the head and neck, and their prevalence is rapidly increasing. HNSCCs present a clinical challenge because of their high recurrence rate, therapeutic resistance to radiation and chemotherapy drugs, and adverse effects. He...
Autores principales: | Hsu, Cheng-Ming, Yang, Ming-Yu, Tsai, Ming-Shao, Chang, Geng-He, Yang, Yao-Hsu, Tsai, Yao-Te, Wu, Ching-Yuan, Chang, Shun-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396193/ https://www.ncbi.nlm.nih.gov/pubmed/34445585 http://dx.doi.org/10.3390/ijms22168881 |
Ejemplares similares
-
6-shogaol is a potential treatment for Head and Neck Squamous Cell Carcinoma
por: Hsu, Cheng-Ming, et al.
Publicado: (2023) -
Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells
por: Lin, Yu-Shih, et al.
Publicado: (2019) -
Induction of ferroptosis and apoptosis in endometrial cancer cells by dihydroisotanshinone I
por: Wu, Ching-Yuan, et al.
Publicado: (2023) -
Dihydroisotanshinone I and BMAL-SIRT1 Pathway in an In Vitro 6-OHDA-Induced Model of Parkinson’s Disease
por: Su, Hui-Chen, et al.
Publicado: (2023) -
Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer
por: Chang, Sheng-Wei, et al.
Publicado: (2021)